Search PubMed⌕ Search

Biomedical subjects

F Galland

Publications and source records attributed to F Galland.

At least 55 records · Page 3Linked to original sources
PubMed1982

[Radioimmunoassay of serum digoxin levels. Clinical exploration (author's transl)].

This work undertakes, in a second part, the clinical exploration of 947 serum digoxin levels of 281 hospitalized patients on a cardiology ward. Our results which coincide with those of other researchers, have led us to draw certain practical conclusions: the posology is determined first of all according to kidney function, weight and age of the patient. When the treatment is insufficient or on the other hand, poorly tolerated, a serum digoxin level is performed permitting thus: 1) in the case of ineffective treatment: to be sure of the patient's cooperation, to increase the posology if the serum digoxin level is not in the toxic zone, to discover an eventual pharmacokinetic problem; 2) to establish the responsibility of digitalis (when there are signs of intolerance or of intoxication), in case of arrhythmia, in patients with pacemakers, when associated drugs are capable of causing similar adverse effects; 3) to better manage a digitalis treatment in a high risk patient (unstable renal function, advanced myocardial disease, chronic obstructive disease).

Adult↗
PubMed1982

[Anti-tumorous effect of bromocriptine in prolactin-secreting adenomas. A case-report (author's transl)].

Bromocriptine inhibits prolactin release. An increasing number of observations, including the one reported in this paper, provide evidence that bromocriptine can also cause significant reduction in the size of prolactin-secreting adenomas. This effect can now be easily demonstrated by CT scanning. Bromocriptine can be used, not only after surgery has failed, but also in order to facilitate the surgical procedure, thereby increasing the surgical success rate. Some authors suggest that prolactin-secreting adenomas be treated with bromocriptine only. Several questions remain open, for instance, why the response to bromocriptine is unpredictable, and whether prolonged therapy with a dopaminergic drug whose effect is not restrained to hypophyseal cells will have adverse side-effects.

Adenoma↗
PubMed1981

[Radioimmunoassay of serum digoxin levels. Technical aspects (author's transl)].

This work analyses, in a first part, radioimmunoassay of serum digoxin levels in more than 4 500 patients during a period of 4 years using the same kit. A preliminary step of this work was to test the kits available 4 years ago i.e a kit using (3H) digoxin and 3 kits using (125I) digoxin. Results about this choice are summarized. The (3H) kit was finally chosen. It was used with slight modifications of the original protocol. This kit was as sensitive as 0.25 ng/ml and was specific for digoxin and its related derivatives. The reproducibility agrees with results in literature. Serum digoxin levels were assayed in the same samples, both with the (3H) kit and (125I) kits. Under these conditions, a lower average value was found with the former system. This result points out that the labelling protocol of the digoxin can modify the apparent normal therapeutic value observed when radioimmunoassay is done with different kits.

Animals↗
PubMed1981

[Radioimmunoassay of serum digoxin levels. Clinical exploration (author's transl)].

This work undertakes, in a second part, the clinical exploration of 947 serum digoxin levels of 281 hospitalized patients on a cardiology ward. Our results, which coincide with those of other researchers, have led us to draw certain practical conclusions: the posology is determined first of all according to kidney function, weight and age of the patient. When the treatment is insufficient or, on the other hand, poorly tolerated, a serum digoxin level is performed permitting thus: 1) in the case of ineffective treatment: to be sure of the patient's cooperation, to increase the posology if the serum digoxin level is not in the toxic zone, to discover an eventual pharmacokinetic problem; 2) to establish the responsibility of digitalis (when there are signs of intolerance or of intoxication), in case of arrhythmia, in patients with pacemakers, when associated drugs are capable of causing similar adverse effects; 3) to better manage a digitalis treatment in a high risk patient (unstable renal function, advanced myocardial disease, chronic obstructive disease).

Age Factors↗
PubMed1979

[Variations in urinary antidiuretic hormone levels related to sodium intake (author's transl)].

Eighteen healthy male subjects, were investigated under normal sodium intake and after 5 days of high and low sodium intake. Under normal sodium intake, the following mean values were observed -- plasma osmolality (Posm): 294 +/- 5 mOsm/kg -- plasma volume (Vp): 33.9 +/- 4,3 ml/kg -- urinary sodium output (UNa.V): 173 +/- 73 mEq/24 h -- urinary antidiuretic hormone (A.D.H.): 68.8 +/- 35.6 ng/24 h. Under low sodium intake these values decreased to -- Posm: 289 +/- 4 m Osm/kg -- Vp: 32.7 +/- 3.2 ml/kg -- UNa.V: 12 +/- 9 mEq/24 h -- A.D.H.: 40.9 +/- 16.3 ng/24 h. Under high sodium intake these values increased to -- Posm: 298 +/- 5 m Osm/kg -- Vp: 36.3 +/- 4.1 ml/kg -- UNa.V: 325 +/- 67 mEq/24 h -- A.D.H.: 118.2 +/- 45.5 NG/24 H. Highly significant correlations are found between Posm and A.D.H. and between the Posm or A.D.H. and UNa.V. Interest is focused on UNa.V since the correlation between A.D.H. and UNa.V (r = 0.78) is more significant than that between A.D.H. and Posm (r = 0.47). Overriding of Posm on Vp in the regulation of A.D.H. secretion is again demonstrated. Plasma renin activity decrease when A.D.H. increase.

Adult↗
PubMed1975

A radiologic index of pulmonary arterial hypertension.

A new radiologic index indicative of pulmonary artery hypertension is presented. It was obtained by measuring the horizontal distances from the midline to the first divisions of the right and left pulmonary arteris, and dividing the sum of these distances by the maximum transverse diameter of the thorax. The index was significantly different in groups with and without pulmonary hypertension and was abnormal (above 38 percent in 111 of 150 patients with cardiovascular disease and pulmonary arterial hypertension (PAH). None of the cases with increased pulmonary flow from cardiac shunts but normal PAP had an anbormal index. Thus, an abnormal index suggested PAH but correlated poorly with the extent of hypertension.

Adolescent↗
PubMedDate not supplied

Vanin genes are clustered (human 6q22-24 and mouse 10A2B1) and encode isoforms of pantetheinase ectoenzymes.

The mouse Vanin-1 molecule plays a role in thymic reconstitution following damage by irradiation. We recently demonstrated that it is a membrane pantetheinase (EC 3.56.1.-). This molecule is the prototypic member of a larger Vanin family encoded by at least two mouse (Vanin-1 and Vanin-3) and three human (VNN1, VNN2, VNN3) orthologous genes. We now report (1) the structural characterization of the human and mouse Vanin genes and their organization in clusters on the 6q22-24 and 10A2B1 chromosomes, respectively; (2) identification of the human VNN3 gene and the demonstration that the mouse Vanin-3 molecule is secreted by cells, and (3) that the Vanin genes encode different isoforms of the mammalian pantetheinase activity. Thus, the Vanin family represents a novel class of secreted or membrane-associated ectoenzymes. We discuss here their possible role in processes pertaining to tissue repair in the context of oxidative stress.

Amidohydrolases↗
PubMedDate not supplied

Cardiac and pulmonary diseases. A pathophysiologic interelationship.

Left heart diseases, in particular mitral stenosis, are often associated with anatomic and functional alterations of the lung. According to the pulmonary structures involved they could be named chronic secondary intersticial and vascular lung diseases. Congenital heart diseases with pre- or post-tricuspid shunts are also often associated with anatomic and functional alterations of the lung. This condition also constitutes a chronic secondary vascular lung disease (atrial septal defect) or a chronic primary vascular lung disease ( ventricular septal defect, patent ductus arteriosus). Primary lung diseases (interstitial pulmonary fibrosis, pulmonary emphysema, recurrent pulmonary embolism) are often associated with right ventricular hypertrophy with or without dilation, a condition commonly named chronic cor pulmonale. On the whole the interrelationships between heart and lung diseases are as follows: a) anatomic and functional alterations of the lung due to left heart diseases are mediated through pulmonary venous hypertension; b) anatomic and functional alterations of the lung due to congenital heart diseases are mediated through the increased pulmonary blood flow with or without transmission of the systemic blood pressure to the pulmonary vasculature, and c) anatomic and functional alterations of the right ventricle due to primary or secondary lung diseases are mediated through arterial pulmonary hypertension. In summary, the interrelationships between heart and lung diseases are mainly mediated through the pulmonary venous or pulmonary arterial hypertension.

Blood Pressure↗